Literature DB >> 26984133

Screaming Behind a Door: The Experiences of Individuals Incarcerated Without Medication-Assisted Treatment.

Shoshana V Aronowitz1, Jennifer Laurent2.   

Abstract

BACKGROUND AND
PURPOSE: Medication-assisted treatment (MAT) is an evidence-based method of treating opioid addiction. Of incarcerated individuals in the United States, 50% to 85% have a history of substance abuse, and > 80% of inmates with opioid addiction history do not receive treatment. The purpose of this study was to explore individuals' experiences after being tapered from MAT upon incarceration.
METHODS: Interpretative phenomenological analysis was employed using in-depth interviewing of 10 participants.
RESULTS: Analysis identified six themes that captured the essence of the participants' experiences. IMPLICATIONS AND
CONCLUSION: Losing MAT upon incarceration was described as an extremely stressful experience for many individuals and may create issues for both inmates and facility staff. Further research is needed to discover ways to improve addiction treatment in prison.
© The Author(s) 2016.

Entities:  

Keywords:  correctional health care; medication-assisted treatment; mental health; opioid maintenance treatment; substance abuse

Mesh:

Year:  2016        PMID: 26984133     DOI: 10.1177/1078345816634079

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  14 in total

1.  Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors:  Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal:  J Subst Abuse Treat       Date:  2019-05-09

Review 2.  The relationship between incarceration history and overdose in North America: A scoping review of the evidence.

Authors:  Sasha Mital; Jessica Wolff; Jennifer J Carroll
Journal:  Drug Alcohol Depend       Date:  2020-05-24       Impact factor: 4.492

3.  Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Authors:  Noa Krawczyk; Caroline E Picher; Kenneth A Feder; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

4.  Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.

Authors:  Kelly E Moore; Walter Roberts; Holly H Reid; Kathryn M Z Smith; Lindsay M S Oberleitner; Sherry A McKee
Journal:  J Subst Abuse Treat       Date:  2018-12-15

5.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

6.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

7.  Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.

Authors:  Kelly E Moore; Lindsay Oberleitner; Kathryn M Z Smith; Kathleen Maurer; Sherry A McKee
Journal:  J Addict Med       Date:  2018 Mar/Apr       Impact factor: 3.702

Review 8.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

9.  Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.

Authors:  Stephanie L Foster; Ewa Galaj; Saumya L Karne; Sergi Ferré; David Weinshenker
Journal:  Addict Biol       Date:  2021-03-25       Impact factor: 4.093

10.  Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.

Authors:  Zoe King; Camille Kramer; Carl Latkin; Carolyn Sufrin
Journal:  J Subst Abuse Treat       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.